Clinical Trials Browser

Interventional × Hodgkin Disease × ofatumumab × Clear all

NCT01195766 2016-02-24

Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma